11.11 -0.17 (-1.50%)
HALO
| Trade HALO now with |
|
Stock Details
Last Trade:11.11 Change:-0.17 (-1.50%) Prev Close:11.28 Open: 11.35 Days Range:10.90 – 11.35 52 Week Range: 5.54 - 11.62 Volume:405175 P/E: N/AEPS:-0.19
View AllRecent Alerts 02/09/12
Recent Alert on 02/09/12 at 4:18pm
Halozyme (HALO) Announces 6.8M Common Offering
Halozyme (HALO) Announces 6.8M Common Offering
Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced that it is offering to sell 6,800,000 shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Barclays Capital Inc. is the sole... Read More
Recent Alert on 12/06/11 at 8:05am
ViroPharma (VPHM), Halozyme (HALO) Report Positive Data from Cinryze, Enhanze Combo in HAE Patients
ViroPharma (VPHM), Halozyme (HALO) Report Positive Data from Cinryze, Enhanze Combo in HAE Patients
Recent Alert on 12/06/11 at 8:05am
ViroPharma (VPHM), Halozyme (HALO) Report Positive Data from Cinryze, Enhanze Combo in HAE Patients
ViroPharma (VPHM), Halozyme (HALO) Report Positive Data from Cinryze, Enhanze Combo in HAE Patients
View AllRecent Press Releases
View AllRecent SEC Filings
SEC Filing on 02/06/12 at 7:40pm
Form 4 HALOZYME THERAPEUTICS For: Feb 02 Filed by: GUSTAFSON KURT A
Form 4 HALOZYME THERAPEUTICS For: Feb 02 Filed by: GUSTAFSON KURT A
SEC Filing on 02/06/12 at 7:31pm
Form 4 HALOZYME THERAPEUTICS For: Feb 02 Filed by: Frost Gregory Ian
Form 4 HALOZYME THERAPEUTICS For: Feb 02 Filed by: Frost Gregory Ian
SEC Filing on 02/06/12 at 7:10pm
Form 4 HALOZYME THERAPEUTICS For: Feb 02 Filed by: Shepard H. Michael
Form 4 HALOZYME THERAPEUTICS For: Feb 02 Filed by: Shepard H. Michael